Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 29 Jan 2016 |
| Notice of Annual Shareholders' meeting 2016 of Novozymes A/S | 28 Jan 2016 |
| The Novozymes Report 2015 | 19 Jan 2016 |
| Group Financial Statement for 2015 | 19 Jan 2016 |
| Trading by management and of close relations to Management | 26 Nov 2015 |